![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Polydrug Laboratories Pvt. Ltd. Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Metoprolol succinate, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R0-CEP 2009-170 - Rev 01
This Chemical Type CEP, issued on March 21, 2012, remains in force until October 26, 2016, ensuring its reliability within the pharmaceutical industry.
Substance Number 1448 associated with this CEP further emphasizes